Artesunate 60mg Injection | Treatment for Severe Malaria

Introduction of Artesunate 60mg Injection

Artesunate 60 mg Injection is a life-saving antimalarial medication used for the treatment of severe malaria, including malaria caused by Plasmodium falciparum. It contains Artesunate, a water-soluble derivative of artemisinin, and is administered intravenously (IV) or intramuscularly (IM) in clinical settings.

Artesunate 60 mg acts rapidly to reduce parasitic load and improve survival rates, especially in critically ill patients. It is widely used in hospitals and emergency care centers, particularly in malaria-endemic regions.

✅ Key Benefits

• Fast-acting antimalarial for emergency use
  
  

• Effective against drug-resistant P. falciparum strains
  
  

• Recommended by WHO as first-line therapy for severe malaria
  
  

• Can be followed by oral antimalarial treatment
  
  

• Suitable for use in children and adults under medical supervision
  
  

✅ Side Effects

Common side effects:

• Dizziness
  
  

• Temporary reduction in red or white blood cells
  
  

• Nausea or injection site pain
  
  

• Low blood pressure (rare)
  
  

✅ Precautions

• Use only under medical supervision
  
  

• Not for self-administration
  
  

• Monitor liver and kidney function during treatment
  
  

• May cause hemolysis in patients with G6PD deficiency
  
  

• Ensure follow-up with oral antimalarial therapy to prevent relapse
  
  

✅ Storage Instructions

• Store below 25°C (77°F)
  
  

• Protect from light and moisture
  
  

• Reconstitute only before administration
  
  

• Use reconstituted solution immediately or as directed
  
  

Artesunate 60 mg Injection is a critically important medicine for the rapid treatment of life-threatening malaria infections. Its fast action, safety profile, and WHO endorsement make it the standard of care for managing severe and complicated malaria. Designed for hospital and emergency use, Artesunate should always be administered by qualified healthcare professionals.